Processing your payment...
Please do not close your browser.

Microneedle Drug Delivery Systems Market - Global Growth, Trends and Forecast (2022 - 2029) By Types (Hollow Microneedle Technology, Solid Microneedle Technology), By Application (Drug Delivery, Vaccine Delivery), By Regions.

07 Sep, 2022 | 112 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global microneedle drug delivery systems market size is expected to reach USD 8.10 billion by 2029 and market is expected to expand at a CAGR of 6.12% from 2022 to 2029

Microneedle Drug Delivery Systems Market Overview

Microneedles are used for drug micro-projections. Microneedles are biological membrane pathways that can be used to create transport pathways of micron dimensions for sampling body fluids, such as measuring blood glucose levels in diabetic therapy. Microneedle drug delivery systems are crucial in the pharmaceutical, biotechnology, and medical industries. Array and microfabrication technologies are widely used in research in medicine, biotechnology, and pharmaceuticals.

The most important driving factor for the microneedle drug delivery system market is the high adoption of a number of emerging safety issues that have short and long term implications for clinicians, patients, healthcare administrators, and regulators, as well as growing research and development initiatives.

Microneedle patch development, as well as an increase in transdermal drug delivery applications for pain management, congestive heart failure, and hormone replacement, will drive the overall microneedle drug delivery system market. Drug degradation, poor absorption, local irritation, and absorption variability are expected to stymie the growth of the microneedle drug delivery system market.

Covid 19 Restricting Pace of Growth

The outbreak of a pandemic has shaken the entire business ecosystem. With production halting and supply chains disrupted due to a lack of transportation, manufacturers of microneedle drug delivery systems are severely impacted.

Furthermore, due to government restrictions such as social distancing, doctors and practitioners are choosing to avoid any surgical treatments that are not absolutely and immediately necessary.

What is our Microneedle Drug Delivery Systems Market report scope?

 

Report Attributes

 

 

Report Details

Forecast Period and CAGR

CAGR of 6.12 % during the review period (2022-2029).

 By Applications

  • Drug Delivery
  •  Vaccine Delivery

 

By Product Type

  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology

 

 

 

By Companies

  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Base Year

2021

Historical Year

2017 to 2021

Forecast Year

2022 to 2029

Number of Pages

112

Customization Available

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

   

Frequently Asked Questions

What is the study period of this market?

The Microneedle Drug Delivery Systems Market is studied from 2017 - 2029.

What is the expected growth rate of Microneedle Drug Delivery Systems Market?

The Microneedle Drug Delivery Systems Market is growing at a CAGR of 6.12 % over the next forecast years.

Which are the key companies operating in the global Microneedle Drug Delivery Systems?

KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Inc, Vaxxas, Lohmann Therapie-Systeme AG

What region does this Microneedle Drug Delivery Systems Market report covers?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Which region is expected to register the fastest revenue CAGR over the forecast period?

Asia Pacific is expected to register a rapid revenue CAGR over the forecast period.

What are the significant types of Microneedle Drug Delivery Systems Market?

Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology

What are the major end-use applications of Microneedle Drug Delivery Systems Market?

Drug Delivery, Vaccine Delivery

Who are the Major Players in Microneedle Drug Delivery Systems Market?

Competitive landscape of the global Microneedle Drug Delivery Systems market comprises key companies on a regional and global level. Key players are engaged in developing innovative and advanced products and solutions to cater to growing global demand and expand their product portfolio to gain a robust footing in the market. Collaborations, mergers and acquisitions, and partnerships are a crucial part in the market.

An exhaustive analysis of the competitive hierarchy of the Microneedle Drug Delivery Systems market is presented in the report and encompasses companies like KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Inc, Vaxxas, Lohmann Therapie-Systeme AG and others.

Recent Developments:

In August 2020, Zosana Pharma Corporation partnered with EVERSANA, a commercial service provider in the life science industry, to commercialize and distribute Qtrypta in the United States. Qtrypta is an intracutaneous patch coated with the drug zolmitriptan for the acute treatment of migraine.

In June 2021, PharmaTher and TSRL entered a co-development agreement to develop microneedle patch delivery technology for psychedelics and antivirals. The alliance has committed to commercializing a patented hydrogel-forming microneedle patch delivery technology.

Microneedle Drug Delivery Systems Market: Segmentation

On the basis of product type, the Microneedle Drug Delivery Systems market in segmented into:

  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology

On the basis of application, the Microneedle Drug Delivery Systems market in segmented into:

  • Drug Delivery
  •  Vaccine Delivery

Microneedle Drug Delivery Systems Market Regional Analysis

North America dominates the global microneedle drug delivery system market because of patient awareness and high per capita health care expenditure. Early-stage disease diagnosis and treatment, as well as simple regulations for transdermal drug delivery vaccines, are driving the medical biotechnology market, which is expected to drive the North American microneedle drug delivery system market. Because of favorable government policies regarding health care infrastructure and disease awareness, Europe is the second largest market for microneedle drug delivery systems. Asia Pacific is expected to grow at a faster rate due to rising population, changing lifestyles, increased patient awareness, and rising per capita expenditure.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Microneedle Drug Delivery Systems Market identifies the market channels and drivers that will drive future worldwide growth prospects. The report also examines market size and share, trends by region, end-use category, and market segment. It puts a lot of emphasis on outlining a thorough regional study. In order to understand the primary influencing factors and entry barriers of the industry, the Global Microneedle Drug Delivery Systems Market research also performed a PESTEL analysis of the sector.

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.

  1. INTRODUCTION
    1. MARKET DEFINITION
    2. MARKET DYNAMICS
    3. MARKET SEGMENTATION
    4. REPORT TIMELINES
    5. KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    1. DATA MINING
      1. SECONDARY RESEARCH
      2. PRIMARY RESEARCH
      3. SUBJECT MATTER EXPERT ADVICE
    2. QUALITY CHECK
    3. FINAL REVIEW
      1. DATA TRIANGULATION
      2. BOTTOM-UP APPROACH
      3. TOP-DOWN APPROACH
    4. RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    1. INTRODUCTION
    2. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET BY APPLICATION
    3. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET BY TYPES
  4. MARKET DYNAMICS
    1. DRIVERS
    2. INCREASING DEMAND FOR GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS RESTRAINTS
      1. STRINGENT ENVIRONMENTAL REGULATIONS
      2. HIGH COST OF RAW MATERIAL
    3. OPPORTUNITIES
      1. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS GROWTH
      2. APPLICATION OF GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS
    4. IMPACT OF COVID 19
  5. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS “MARKET, BY TYPES
    1. INTRODUCTION
      1. HOLLOW MICRONEEDLE TECHNOLOGY
      2. SOLID MICRONEEDLE TECHNOLOGY
      3. DISSOLVING MICRONEEDLES TECHNOLOGY
  6. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION
    1. INTRODUCTION
      1. DRUG DELIVERY
      2.  VACCINE DELIVERY
  7. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET, BY REGION
    1. NORTH AMERICA
      1. US
      2. CANADA
      3. MEXICO
    2. EUROPE
      1. GERMANY
      2. FRANCE
      3. UK
      4. ITALY
      5. RUSSIA
      6. REST OF EUROPE
    3. APAC
      1. CHINA
      2. SOUTH KOREA
      3. JAPAN
      4. INDIA
      5. AUSTRALIA
      6. ASIAN
      7. REST OF APAC
    4. MIDDLE EAST & AFRICA
      1. SAUDI ARABIA
      2. UAE
      3. SOUTH AFRICA
      4. TURKEY
      5. REST OF MEA
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF MEA
      3. ARGENTINA
      4. REST OF SOUTH AMERICA
  8. COMPETITIVE LANDSCAPE
    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    2. AND AGREEMENTS
      1. KEY DEVELOPMENT
    3. MARKET SHARE RANKING ANALYSIS
    4. STRATEGIES ADOPTED BY LEADING PLAYERS
  9. COMPANY PROFILES
    1. BUSINESS OVERVIEW
    2. COMPANY SNAPSHOT
    3. PRODUCT BENCHMARKING
    4. STRATEGIC INITIATIVES
      1. KINDEVA
      2. ZOSANO PHARMA
      3. BECTON-DICKINSON(BD)TECHNOLOGIES
      4. NANOPASS TECHNOLOGIES
      5. CORIUM
      6. VALERITAS
      7. NITTO
      8. MICRODERMICS
      9. THERAJECT, INC
      10. VAXXAS
      11. LOHMANN THERAPIE-SYSTEME AG

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla